Catalyst Wire Dossier Catalyst Wire Dossier

Lactobacillus brevis CD2 (probiotic)

Lactobacillus brevis CD2 · University of Roma La Sapienza
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lactobacillus brevis CD2 (probiotic), covering 2013-03-25 to 2013-03-25. Get the full timeline:

Most recent: Clinical Trial Update: L. Brevis CD2 Strain Persistence in Oral Cavity [NA]

See pricing